We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONTO:NYSEOnto Innovation Inc. analysis

Data as of Oct 17, 2026 - not real-time

Latest price
$220.70
Risk: high
9/10High risk

Summary

Onto Innovation Inc. trades at $220.70, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 12.6%. Momentum indicators put RSI at 29.0 (oversold) with MACD reading bearish. Watch $219.91 as support and $339.04 as the nearer resistance level.
Multiples put this in fair territory: 83.0 times earnings against the sector's 30.0. The average analyst target implies 75.6% above today's level. Revenue is growing at 35.3% on a 11.8% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 70.8%, a beta of 3.11 and a maximum drawdown of 42.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top market events

  • Onto Innovation stock is trading near recent highs as of September 18, 2026, backed by strong Q1 202
  • Onto Innovation stock delivered adjusted EPS of USD 1.
  • BUFFALO Funds, an actively managed mutual fund advised by Kornitzer Capital Management, released its second-quarter...

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • RSI at 29.0 signals oversold conditions
  • Trading below the 200-day average of 259.56
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • RSI at 29.0 signals oversold conditions
  • P/E of 83.0 versus sector average of 30.0
  • Trading below the 200-day average of 259.56

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 83.0 versus sector average of 30.0
  • Analyst targets imply +75.6% versus the current price
  • Revenue growth of +35.3%

Key metrics

Financial health

Revenue Growth35.30%
Profit Margin11.84%
P/E Ratio83.0
ROE6.83%
ROA4.81%
Debt/Equity76.55
P/B Ratio5.6
Op. Cash Flow$266.2M
Free Cash Flow$202.9M
Industry P/E30.0

Technical analysis

TrendNeutral
RSI29.0
Support$219.91
Resistance$339.04
MA 20$285.77
MA 50$285.79
MA 200$259.56
MACDBearish
VolumeIncreasing
Fear & Greed Index85.73

Valuation

Fair Value$144.32
Target Price$387.50
Upside/Downside75.58%
GradeFair
TypeGrowth

Risk assessment

Beta3.11
Volatility70.82%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.